شیمی دارویی داروپخش
دشیمی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 38,950 2.99
Close Price: 38,970
Financial Ratios
AGM
Interim
2026/07/07 Fiscal Year 2026/03/2012 Month | 2025/05/19 Fiscal Year 2025/03/2012 Month | 2024/05/18 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 16.06 | 8.56 | 26.88 | |
Gross Profit to Sales | 18.07 | 10.36 | 34.61 | |
Operating Margin | 24.69 | 14.69 | 36.73 | |
Gross Profit to Sales | 32.7 | 25.37 | 38.45 | |
Net Profit to Gross Profit | 49.1 | 33.75 | 69.93 | |
Return on Assets (ROA) | 12.41 | 2.55 | 30.96 | |
Return on Capital (%) | 207.33 | 91.33 | 419.99 | |
Return on Equity (ROE) | 44.87 | 3.81 | 76.5 | |
Working Capital Return | 52.55 | 34.83 | 89.34 | |
Fixed Asset Return | 171.06 | 4.2 | 380.93 | |
Loan Benefit Assessment | 3.61 | 1.49 | 2.47 | |
Current Ratio | 1.34 | 1.23 | 1.61 | |
Quick Ratio | 1.13 | 0.95 | 1.06 | |
Liquidity Ratio | 0.03 | 0.07 | 0.01 | |
Net Working Capital | 3,550,669 | 2,359,822 | 4,231,039 | |
Current Assets Ratio | 0.92 | 0.39 | 0.92 | |
Inventory Turnover | 117.93 | 170.12 | 160.3 | |
Receivables Collection Period | 252.6 | 280.11 | 156.29 | |
Inventory to Working Capital | 0.61 | 1.22 | 0.9 | |
Working Capital Turnover | 3.27 | 4.07 | 3.32 | |
Fixed Asset Turnover | 10.65 | 0.49 | 14.17 | |
Total Asset Turnover | 0.77 | 0.3 | 1.15 | |
Debt Ratio | 0.72 | 0.33 | 0.6 | |
Debt to Equity | 2.61 | 0.49 | 1.47 | |
Long-Term Debt to Equity | 0.14 | 0.02 | 0.06 | |
Current Debt to Equity | 2.48 | 0.48 | 1.41 | |
Equity Ratio | 27.67 | 66.9 | 40.47 | |
Debt Coverage Ratio | 1.93 | 52.56 | 3.1 |
